Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern

Annals of the Rheumatic Diseases

Volumn 71, Issue 3, 2012, Pages 334-340

  Ambrosi, Aurélie ^a   Salomonsson, Stina ^a   Eliasson, Håkan ^a   Zeffer, Elisabeth ^a   Skog, Amanda ^a   Dzikaite, Vijole ^a   Bergman, Gunnar ^a   Fernlund, Eva ^b   Tingström, Joanna ^a   Theander, Elke ^b   Rydberg, Annika ^c   Skogh, Thomas ^d   Öhman, Annika ^e   Lundström, Ulla ^f   Mellander, Mats ^f   Winqvist, Ola ^a   Fored, Michael ^a   Ekbom, Anders ^a   Alfredsson, Lars ^a   Källberg, Henrik ^a   Olsson, Tomas ^a   Gadler, Fredrik ^a   Jonzon, Anders ^e   Kockum, Ingrid ^a   Sonesson, Sven Erik ^a   Wahren Herlenius, Marie ^a   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LA ANTIBODY; RO ANTIBODY; VITAMIN D;

ADULT; ARTICLE; CHILD; CHILDBIRTH; COHORT ANALYSIS; CONGENITAL HEART BLOCK; FAMILY STUDY; FEMALE; FETOPLACENTAL UNIT; GENDER; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PARITY; POPULATION RESEARCH; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SEASONAL VARIATION; SWEDEN;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BIRTH ORDER; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FEMALE; HEART BLOCK; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL AGE; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RECURRENCE; RISK FACTORS; SEASONS; SEX FACTORS; SWEDEN; VITAMIN D; YOUNG ADULT;

EID: 84857237951     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200207     Document Type: Article

References (29)

1. Salomonsson S, Strandberg L. Autoantibodies associated with congenital heart block. Scand J Immunol 2010;72:185-8.
2. Brucato A, Previtali E, Ramoni V, et al. Arrhythmias presenting in neonatal lupus. Scand J Immunol 2010;72:198-204.
3. Cimaz R, Spence DL, Hornberger L, et al. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003;142:678-83. (Pubitemid 36737172)
4. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004;50:3187-94. (Pubitemid 39371995)
5. Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5. (Pubitemid 32758230)
6. Hornberger LK, Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol 2010;72:189-97.
7. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66. (Pubitemid 28273312)
8. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001;44:487-8.
9. Solomon DG, Rupel A, Buyon JP. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 2003;12:646-7. (Pubitemid 37021804)
10. Strandberg L, Salomonsson S, Bremme K, et al. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies. Lupus 2006;15:346-53. (Pubitemid 44032709)
11. Strandberg LS, Ambrosi A, Jagodic M, et al. Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block. J Immunol 2010;185:3574-82.
12. Wahren-Herlenius M, Sonesson SE. Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol 2006;18:690-6. (Pubitemid 44635180)
13. Clancy RM, Backer CB, Yin X, et al. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003;171:3253-61. (Pubitemid 37093552)
14. Cimaz R, Borghi MO, Gerosa M, et al. Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block: lesson from twins and triplets discordant for the disease. Arthritis Rheum 2006;54:356-9. (Pubitemid 43122220)
15. Eronen M, Miettinen A, Walle TK, et al. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block. Acta Paediatr 2004;93:803-9. (Pubitemid 38736816)
16. Salomonsson S, Dzikaite V, Zeffer E, et al. A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block. Scand J Immunol. Published Online First: 4 August 2011. doi: 10.1111/j.1365-3083.2011.02610.x
17. Brucato A, Jonzon A, Friedman D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus 2003;12:427-35. (Pubitemid 36830115)
18. Salomonsson S, Dörner T, Theander E, et al. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-41. (Pubitemid 34525831)
19. Hedström AK, Bäärnhielm M, Olsson T, et al. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009;73:696-701.
20. Villain E, Coastedoat-Chalumeau N, Marijon E, et al. Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol 2006;48:1682-7. (Pubitemid 44528193)
21. Willer CJ, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.
22. Julkunen H, Kaaja R, Wallgren E, et al. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993;82:11-16. (Pubitemid 23200535)
23. Llanos C, Izmirly PM, Katholi M, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009;60:3091-7.
24. Skog A, Wahren-Herlenius M, Sundström B, et al. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Pediatrics 2008;121:e803-9.
25. Montan S. Increased risk in the elderly parturient. Curr Opin Obstet Gynecol 2007;19:110-12. (Pubitemid 46412098)
26. Clancy RM, Zheng P, O'Mahony M, et al. Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis Rheum 2007;56:4120-31. (Pubitemid 350262340)
27. Cooley HM, Keech CL, Melny BJ, et al. Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum 1997;40:381-4. (Pubitemid 27114102)
28. Spence D, Hornberger L, Hamilton R, et al. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies. J Rheumatol 2006;33:167-70. (Pubitemid 43054298)
29. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008;8:685-98.